- Home
- ORIC vs VREX Comparison
ORIC vs VREX Comparison
Compare ORIC & VREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- VREX
- Stock Information
- Founded
- ORIC 2014
- VREX 2016
- Country
- ORIC United States
- VREX United States
- Employees
- ORIC N/A
- VREX N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- VREX Industrial Machinery/Components
- Sector
- ORIC Health Care
- VREX Technology
- Exchange
- ORIC Nasdaq
- VREX Nasdaq
- Market Cap
- ORIC 633.7M
- VREX 582.3M
- IPO Year
- ORIC 2020
- VREX N/A
- Fundamental
- Price
- ORIC $9.91
- VREX $13.52
- Analyst Decision
- ORIC Strong Buy
- VREX Strong Buy
- Analyst Count
- ORIC 9
- VREX 1
- Target Price
- ORIC $18.75
- VREX $21.00
- AVG Volume (30 Days)
- ORIC 499.9K
- VREX 482.8K
- Earning Date
- ORIC 11-12-2024
- VREX 02-04-2025
- Dividend Yield
- ORIC N/A
- VREX N/A
- EPS Growth
- ORIC N/A
- VREX N/A
- EPS
- ORIC N/A
- VREX N/A
- Revenue
- ORIC N/A
- VREX $811,000,000.00
- Revenue This Year
- ORIC N/A
- VREX $3.50
- Revenue Next Year
- ORIC N/A
- VREX $3.37
- P/E Ratio
- ORIC N/A
- VREX N/A
- Revenue Growth
- ORIC N/A
- VREX N/A
- 52 Week Low
- ORIC $6.33
- VREX $10.19
- 52 Week High
- ORIC $16.65
- VREX $20.27
- Technical
- Relative Strength Index (RSI)
- ORIC 61.23
- VREX 35.86
- Support Level
- ORIC $7.86
- VREX $13.12
- Resistance Level
- ORIC $9.47
- VREX $14.85
- Average True Range (ATR)
- ORIC 0.57
- VREX 0.44
- MACD
- ORIC 0.16
- VREX -0.14
- Stochastic Oscillator
- ORIC 93.47
- VREX 18.69
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital flat panel image detectors, high voltage connectors, ionization chambers, and buckys among others. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors and high voltage connectors among others. It has manufacturing, research, and development operation in the United States, Europe, Philippines and China, and sales and service operations throughout the world.